Pharmacy

U.S. Senate Finance Committee Chairman Chuck Grassley, R-Iowa, has asked Novartis to provide company records and details about data manipulation related to FDA approval of its $2 million gene therapy Zolgensma, according to EndPoints News.

An Oklahoma pharmacy owner has pleaded guilty to taking part in a $1.1 million scheme that defrauded health insurance providers, according to KFOR-TV.

Walmart soon will open a 1,500-square-foot retail space and pharmacy in a Toyota plant in Mississippi, according to the Daily Journal. 

Several drugs entered the U.S. market in 2019, some of which could generate at least $1 billion in annual sales by 2024, according to market research firm EvaluatePharma.

John O'Brien, the senior adviser to HHS Secretary Alex Azar on drug-pricing reform, will step down from his position Aug. 22.

Canadians, furious about the Trump administration's plan to allow the importation of their prescription drugs, are discussing several ways to stop the proposal, according to STAT.

Most insurers and pharmacy benefit managers haven't placed the cheaper version of insulin manufactured by Eli Lilly on their lists of covered drugs, according to the Financial Times.

Rite Aid, a drugstore chain with 2,466 stores across the country, has named Heyward Donigan CEO, effective immediately.

Drugmakers are striking deals with hospital systems to mine the genetic profiles of patients, igniting concerns about the control of this genetic data, according to The Wall Street Journal.

Daiichi Sankyo, which has a U.S. headquarters in Basking Ridge, N.J., will lay off 69 members of its opioid pain medication sales force by October, according to ROI-NJ.com.